{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:25:46Z","timestamp":1791663946266,"version":"4.3.4"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T00:00:00Z","timestamp":1527724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ijidonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ijid.2018.05.017","type":"journal-article","created":{"date-parts":[[2018,6,2]],"date-time":"2018-06-02T16:07:08Z","timestamp":1527955628000},"page":"48-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Importance of control groups when delineating antibiotic use as a risk factor for carbapenem resistance, extreme-drug resistance, and pan-drug resistance in Acinetobacter baumannii and Pseudomonas aeruginosa: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2533-9751","authenticated-orcid":false,"given":"Cheryl Li Ling","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin Qijia","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn Qi Min","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiying","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Lay-Hoon","family":"Kwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2018.05.017_bib0005","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s10096-007-0371-8","article-title":"Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes","volume":"26","author":"Abbo","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"11","key":"10.1016\/j.ijid.2018.05.017_bib0010","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1128\/AAC.43.11.2624","article-title":"Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides","volume":"43","author":"Aires","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2018.05.017_bib0015","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1128\/AAC.49.6.2543-2545.2005","article-title":"Selection of cross resistance following exposure of Pseudomonas aeruginosa clinical isolates to ciprofloxacin or cefepime","volume":"49","author":"Alayseen","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.ijid.2018.05.017_bib0020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1086\/502018","article-title":"The cost of antibiotic resistance: effect of resistance among Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa on length of hospital stay","volume":"23","author":"Anon","year":"2002","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"10.1016\/j.ijid.2018.05.017_bib0025","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/jac\/29.3.307","article-title":"Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy","volume":"29","author":"Aubert","year":"1992","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2018.05.017_bib0030","doi-asserted-by":"crossref","first-page":"66","DOI":"10.7883\/yoken.65.66","article-title":"Mortality attributable to carbapenem-resistant nosocomial Acinetobacter baumannii infections in a Turkish University Hospital","volume":"65","author":"Aydemir","year":"2012","journal-title":"Jpn J Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2018.05.017_bib0035","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijid.2007.03.005","article-title":"Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections","volume":"12","author":"Baran","year":"2008","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2018.05.017_bib0040","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s10156-007-0557-0","article-title":"Epidemiology and risk factors for colonization and infection by Acinetobacter baumannii in an ICY in Tunisia, where this pathogen is endemic","volume":"13","author":"Brahmi","year":"2007","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijid.2018.05.017_bib0045","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0195-6701(97)90250-4","article-title":"Epidemiological study of variations in beta-lactam antibiotic susceptibility of Pseudomonas aeruginosa in two intensive care units","volume":"37","author":"Cailleaux","year":"1997","journal-title":"J Hosp Infect"},{"issue":"8","key":"10.1016\/j.ijid.2018.05.017_bib0050","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3109\/00365548.2014.920103","article-title":"Risk factors for the acquisition of imipenem-resistant Acinetobacter baumannii in a burn unit: an appraisal of the effect of colonization pressure","volume":"46","author":"Calvalcante Rde","year":"2014","journal-title":"Scand J Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2018.05.017_bib0055","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jhin.2004.07.027","article-title":"Investigation of a nosocomial outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a hospital Setting","volume":"60","author":"Carbonne","year":"2005","journal-title":"J Hosp Infect"},{"issue":"10","key":"10.1016\/j.ijid.2018.05.017_bib0060","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1001\/archinte.159.10.1127","article-title":"Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa","volume":"159","author":"Carmeli","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijid.2018.05.017_bib0065","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1001\/archinte.159.20.2461","article-title":"The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis","volume":"159","author":"Carmeli","year":"1999","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.ijid.2018.05.017_bib0070","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1128\/AAC.43.6.1379","article-title":"Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents","volume":"43","author":"Carmeli","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.ijid.2018.05.017_bib0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085973","article-title":"Risk factors for healthcare-associated extensively drug-resistant Acinetobacter baumannii infections: a case-control study","volume":"9","author":"Chan","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ijid.2018.05.017_bib0080","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jecm.2014.06.003","article-title":"Risk factors of carbapenem-resistant Acinetobacter baumannii infection among hospitalized patients","volume":"6","author":"Chen","year":"2014","journal-title":"J Exp Clin Med"},{"issue":"4","key":"10.1016\/j.ijid.2018.05.017_bib0085","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s10096-014-2281-x","article-title":"Control of hospital endemicity of multiple-drug-resistant Acinetobacter baumannii ST457 with directly observed hand hygiene","volume":"34","author":"Cheng","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"12","key":"10.1016\/j.ijid.2018.05.017_bib0090","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.1128\/AAC.01520-13","article-title":"Epidemiology of bloodstream infections caused by Acinetobacter baumannii and impact of drug resistance to both carbapenems and ampicillin-sulbactam on clinical outcomes","volume":"57","author":"Chopra","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.ijid.2018.05.017_bib0095","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jiac.2014.10.002","article-title":"Impact of antibiotic exposure on occurrence of nosocomial carbapenem-resistant Acinetobacter baumannii infection: a case control study","volume":"21","author":"Chusri","year":"2015","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijid.2018.05.017_bib0100","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1469-0691.2005.01256.x","article-title":"Risk factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study","volume":"11","author":"Cisneros","year":"2005","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"10.1016\/j.ijid.2018.05.017_bib0105","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1128\/JCM.38.11.4086-4095.2000","article-title":"Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii","volume":"38","author":"Corbella","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.ijid.2018.05.017_bib0110","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4103\/0972-5229.76089","article-title":"Prevalence of metallo-B-lactamase producing Pseudomonas aeruginosa and Acinetobacter species in intensive care areas in a tertiary care hospital","volume":"14","author":"De","year":"2010","journal-title":"Indian J Crit Care Med"},{"key":"10.1016\/j.ijid.2018.05.017_bib0115","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3109\/00365548.2010.489568","article-title":"Nosocomial imipenem-resistant Acinetobacter baumannii infections: epidemiology and risk Factors","volume":"42","author":"Dizbay","year":"2010","journal-title":"Scand J Infect Dis"},{"issue":"9","key":"10.1016\/j.ijid.2018.05.017_bib0120","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3855\/jidc.3516","article-title":"Risk factors for carbapenem-resistant Pseudomonas aeruginosa infection in a tertiary care hospital in Serbia","volume":"7","author":"Djordjevic","year":"2013","journal-title":"J Infect Dev Ctries"},{"issue":"8","key":"10.1016\/j.ijid.2018.05.017_bib0125","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1086\/603527","article-title":"Risk factors and outcomes associated with isolation of meropenem high-level-resistant Pseudomonas aeruginosa","volume":"30","author":"Eagye","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijid.2018.05.017_bib0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jhin.2006.04.015","article-title":"Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature","volume":"64","author":"Falagas","year":"2006","journal-title":"J Hosp Infect"},{"issue":"7","key":"10.1016\/j.ijid.2018.05.017_bib0135","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1128\/AAC.00224-06","article-title":"Risk factors for isolation of strains susceptible only to polymyxin among patients with Pseudomonas aeruginosa bacteremia","volume":"50","author":"Falagas","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.ijid.2018.05.017_bib0140","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1086\/501822","article-title":"An outbreak of imipenem-resistant Acinetobacter baumannii in critically ill surgiacal patients","volume":"22","author":"Fierobe","year":"2001","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"9","key":"10.1016\/j.ijid.2018.05.017_bib0145","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1086\/507288","article-title":"Risk factors for recovery of imipenem or ceftazidime-resistant Pseudomonas aeruginosa among patients admitted to a teaching hospital in Brazil","volume":"27","author":"Fortaleza","year":"2006","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijid.2018.05.017_bib0150","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1086\/500202","article-title":"The epidemiology and control of Acinetobacter baumannii in health care facilities","volume":"42","author":"Fournier","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ijid.2018.05.017_bib0155","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ajic.2015.03.033","article-title":"Risk factors for extensive drug-resistance and mortality in geriatric inpatients with bacteremia caused by Acinetobacter baumannii","volume":"43","author":"Fu","year":"2015","journal-title":"Am J Infect Control"},{"issue":"4","key":"10.1016\/j.ijid.2018.05.017_bib0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2009.03.006","article-title":"Imipenem-resistant Pseudomonas aeruginosa infection at a medical-surgical intensive care unit: risk factors and mortality","volume":"24","author":"Furtado","year":"2009","journal-title":"J Crit Care"},{"issue":"6","key":"10.1016\/j.ijid.2018.05.017_bib0165","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1177\/0310057X1003800605","article-title":"Risk factors for hospital-acquired pneumonia caused by imipenem-resistant Pseudomonas aeruginosa in a intensive care unit","volume":"38","author":"Furtado","year":"2010","journal-title":"Anaesth Intensive Care"},{"issue":"9","key":"10.1016\/j.ijid.2018.05.017_bib0170","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1097\/00003246-199909000-00015","article-title":"Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients","volume":"27","author":"Garcia-Garmendia","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijid.2018.05.017_bib0175","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00134-005-2598-0","article-title":"Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings","volume":"31","author":"Garnacho-Montero","year":"2005","journal-title":"Intensive Care Med"},{"issue":"12","key":"10.1016\/j.ijid.2018.05.017_bib0180","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1086\/340533","article-title":"Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci and Escherichia coli","volume":"34","author":"Harris","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2018.05.017_bib0185","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1086\/338237","article-title":"Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients","volume":"34","author":"Harris","year":"2002","journal-title":"CIin Infect Dis"},{"issue":"7","key":"10.1016\/j.ijid.2018.05.017_bib0190","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1086\/660763","article-title":"Risk factors for development of intestinal colonization with imipenem-resistant Pseudomonas aeruginosa in the intensive care unit setting","volume":"32","author":"Harris","year":"2011","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijid.2018.05.017_bib0195","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jmii.2011.12.009","article-title":"Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia","volume":"45","author":"Huang","year":"2012","journal-title":"J Microbiol Immunol Infect"},{"issue":"5","key":"10.1016\/j.ijid.2018.05.017_bib0200","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1378\/chest.115.5.1378","article-title":"Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosocomial pneumonia among intubated patients","volume":"115","author":"Husni","year":"1999","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.ijid.2018.05.017_bib0205","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jiac.2015.04.010","article-title":"Risk factors of multidrug-resistant, extensively drug-resistant and pandrug-resistant Acinetobacter baumannii ventilator-associated pneumonia in a Medical Intensive Care Unit of University Hospital in Thailand","volume":"21","author":"Inchai","year":"2015","journal-title":"J Infect Chemother"},{"issue":"1","key":"10.1016\/j.ijid.2018.05.017_bib0210","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1089\/mdr.2005.11.68","article-title":"Risk factors for antimicrobial resistance and influence of resistance on mortality in patients with bloodstream infection caused by Pseudomonas aeruginosa","volume":"11","author":"Kang","year":"2005","journal-title":"Microb Drug Resist"},{"issue":"6","key":"10.1016\/j.ijid.2018.05.017_bib0215","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1007\/s00268-008-9571-3","article-title":"Acinetobacter baumannii infections in a surgical intensive care unit: predictors of multi-drug resistance","volume":"32","author":"Katsaragakis","year":"2008","journal-title":"World J Surg"},{"key":"10.1016\/j.ijid.2018.05.017_bib0220","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/00365540701633004","article-title":"Risk factors and outcomes of bloodstream infections with metallo-B-lactamase-producing Acinetobacter","volume":"40","author":"Kim","year":"2008","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijid.2018.05.017_bib0225","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3346\/jkms.2012.27.5.471","article-title":"Risk factors for mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia: impact of appropriate antimicrobial therapy","volume":"27","author":"Kim","year":"2012","journal-title":"J Korean Med Sci"},{"issue":"8","key":"10.1016\/j.ijid.2018.05.017_bib0230","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3346\/jkms.2012.27.8.939","article-title":"Risk factors for occurrence and 30-day mortality for carbapenem-resistant Acinetobacter baumannii bacteremia in an intensive care Unit","volume":"27","author":"Kim","year":"2012","journal-title":"J Korean Med Sci"},{"issue":"2","key":"10.1016\/j.ijid.2018.05.017_bib0235","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0195-6701(97)90181-X","article-title":"Nosocomial outbreak of multi-resistant Acinetobacter baumannii on a surgical ward: epidemiology and risk factors for acquisition","volume":"37","author":"Koeleman","year":"1997","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijid.2018.05.017_bib0240","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jhin.2009.10.024","article-title":"Outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a surgical intensive care unit","volume":"74","author":"Kohlenberg","year":"2010","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijid.2018.05.017_bib0245","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ijantimicag.2007.06.026","article-title":"Exposure to quinolones is associated with carbapenem resistance among colistin-susceptible Acinetobacter baumannii blood isolates","volume":"30","author":"Kopterides","year":"2007","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"10.1016\/j.ijid.2018.05.017_bib0250","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1086\/507274","article-title":"Imipenem resistance among Pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes","volume":"27","author":"Lautenbach","year":"2006","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"12","key":"10.1016\/j.ijid.2018.05.017_bib0255","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1086\/648450","article-title":"Epidemiology and impact of imipenem resistance in Acinetobacter baumannii","volume":"30","author":"Lautenbach","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"10.1016\/j.ijid.2018.05.017_bib0260","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1086\/649021","article-title":"Imipenem resistance in Pseudomonas aeruginosa: emergence, epidemiology and impact on clinical and economic outcomes","volume":"31","author":"Lautenbach","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"10.1016\/j.ijid.2018.05.017_bib0265","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1128\/AAC.48.1.224-228.2004","article-title":"Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study","volume":"48","author":"Lee","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.ijid.2018.05.017_bib0270","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ijantimicag.2010.12.015","article-title":"Imipenem heteroresistance induced by imipenem in multidrug-resistant Acinetobacter baumannii: mechanism and clinical implications","volume":"37","author":"Lee","year":"2011","journal-title":"Int J Antimicrob Agents"},{"issue":"October(5)","key":"10.1016\/j.ijid.2018.05.017_bib0275","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jmii.2015.06.003","article-title":"Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems","volume":"50","author":"Lee","year":"2017","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"10.1016\/j.ijid.2018.05.017_bib0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diagmicrobio.2009.08.014","article-title":"Imipenem-resistant Pseudomonas aeruginosa gastrointestinal carriage among hospitalized patients: risk factors and resistance mechanisms","volume":"66","author":"Lepelletier","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.ijid.2018.05.017_bib0285","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2307\/30141136","article-title":"An outbreak of multiresistant Acinetobacter baumanii in a university hospital in Sao Paulo, Brazil","volume":"17","author":"Levin","year":"1996","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijid.2018.05.017_bib0290","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ajic.2012.02.025","article-title":"Risk factors for extreme-drug-resistant Pseudomonas aeruginosa infections in patients with hematologic malignancies","volume":"41","author":"Liew","year":"2013","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ijid.2018.05.017_bib0295","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajic.2009.03.008","article-title":"Clinical features and molecular epidemiology of multidrug-resistant Acinetobacter calcoaceticus-A baumannii complex in a regional teaching hospital in Taiwan","volume":"37","author":"Lin","year":"2009","journal-title":"Am J Infect Control"},{"issue":"1","key":"10.1016\/j.ijid.2018.05.017_bib0300","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jmii.2014.01.005","article-title":"Carbapenem-resistant Pseudomonas aeruginosa in Taiwan: prevalence, risk factors and impact on outcome of infections","volume":"49","author":"Lin","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"issue":"3","key":"10.1016\/j.ijid.2018.05.017_bib0305","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jac\/47.3.247","article-title":"Of Pseudomonas, porins, pumps and carbapenems","volume":"47","author":"Livermore","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.ijid.2018.05.017_bib0310","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1086\/518972","article-title":"Identification of patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk of infection with carbapenem-resistant isolates","volume":"28","author":"Lodise","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijid.2018.05.017_bib0315","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magioakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"10.1016\/j.ijid.2018.05.017_bib0320","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1067\/mic.2002.122648","article-title":"Underlying characteristics of patients harboring highly resistant Acinetobacter baumannii","volume":"30","author":"Mahgoub","year":"2002","journal-title":"Am J Infect Control"},{"issue":"3","key":"10.1016\/j.ijid.2018.05.017_bib0325","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4103\/0974-777X.68538","article-title":"Multidrug resistant Acinetobacter","volume":"2","author":"Manchanda","year":"2010","journal-title":"J Glob Infect Dis"},{"issue":"9","key":"10.1016\/j.ijid.2018.05.017_bib0330","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s00134-007-0683-2","article-title":"Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa","volume":"33","author":"Mentzelopoulos","year":"2007","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijid.2018.05.017_bib0335","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13756-015-0067-2","article-title":"Epidemiology of carbapenem non-susceptible Pseudomonas aeruginosa isolates in Eastern Algeria","volume":"4","author":"Meradji","year":"2015","journal-title":"Antimicrob Resist Infect Control"},{"issue":"4","key":"10.1016\/j.ijid.2018.05.017_bib0340","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.burns.2016.02.023","article-title":"Epidemiology and virulence of VIM-4 metallo-beta-lactamase-producing Pseudomonas aeruginosa isolated from burn patients in eastern Algeria","volume":"42","author":"Meradji","year":"2016","journal-title":"Burns"},{"issue":"1","key":"10.1016\/j.ijid.2018.05.017_bib0345","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jhin.2015.10.007","article-title":"Extensively drug-resistant Acinetobacter baumannii in a Lebanese intensive care unit: risk factors for acquisition and determination of a colonization score","volume":"92","author":"Moghnieh","year":"2016","journal-title":"J Hosp Infect"},{"issue":"1","key":"10.1016\/j.ijid.2018.05.017_bib0350","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jhin.2015.10.007","article-title":"Extensively drug-resistant Acinetobacter baumannii in a Lebanese intensive care unit: risk factors for acquisition and determination of a colonization score","volume":"92","author":"Moghnieh","year":"2016","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijid.2018.05.017_bib0355","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10096-009-0850-1","article-title":"Risk factors for multidrug-resistant Pseudomonas aeruginosa acquisition. Impact of antibiotic use in a double case-control study","volume":"29","author":"Montero","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"10","key":"10.1016\/j.ijid.2018.05.017_bib0360","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1592\/phco.2005.25.10.1353","article-title":"Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options","volume":"25","author":"Obrisch","year":"2005","journal-title":"Pharmacotherapy"},{"issue":"10","key":"10.1016\/j.ijid.2018.05.017_bib0365","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1592\/phco.2005.25.10.1353","article-title":"Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options","volume":"25","author":"Obritsch","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijid.2018.05.017_bib0370","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3346\/jkms.2008.23.6.982","article-title":"Imipenem-resistant Pseudomonas aeruginosa: risk factors for nosocomial infections","volume":"23","author":"Onguru","year":"2008","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.ijid.2018.05.017_bib0375","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.burns.2005.04.015","article-title":"The risk factors for acquisition of imipenem-resistant Pseudomonas aeruginosa in the burn unit","volume":"31","author":"Ozkurt","year":"2005","journal-title":"Burns"},{"issue":"5","key":"10.1016\/j.ijid.2018.05.017_bib0380","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1086\/381550","article-title":"Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity","volume":"38","author":"Paramythiotou","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ijid.2018.05.017_bib0385","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ijantimicag.2010.06.049","article-title":"Extensively drug-resistant Acinetobacter baumannii: risk factors for acquisition and prevalent OXA-type Carbapenemases\u2014a multicentre study","volume":"36","author":"Park","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.ijid.2018.05.017_bib0390","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jhin.2011.05.014","article-title":"Acquisition of extensive drug-resistant Pseudomonas aeruginosa among hospitalized patients: risk factors and resistance mechanisms to carbapenems","volume":"79","author":"Park","year":"2011","journal-title":"J Hosp Infect"},{"issue":"1","key":"10.1016\/j.ijid.2018.05.017_bib0395","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/jac\/dkl441","article-title":"Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report","volume":"59","author":"Peleg","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.ijid.2018.05.017_bib0400","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1128\/AAC.01483-06","article-title":"Effects of carbapenem exposure on the risk of digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients","volume":"51","author":"Pena","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2018.05.017_bib0405","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10096-008-0645-9","article-title":"Carbapenem-resistant Pseudomonas aeruginosa: factors influencing multidrug-resistant acquisition in non-critically ill patients","volume":"28","author":"Pena","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"10","key":"10.1016\/j.ijid.2018.05.017_bib0410","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1007\/s10096-012-1629-3","article-title":"EXtensively drug-resistant Pseudomonas aeruginosa: risk of bloodstream infection in hospitalized patients","volume":"31","author":"Pena","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.ijid.2018.05.017_bib0415","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1086\/588163","article-title":"Controlling the clonal spread of Pseudomonas aeruginosa infection","volume":"29","author":"Pereira","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijid.2018.05.017_bib0420","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jhin.2006.11.010","article-title":"Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences","volume":"65","author":"Playford","year":"2007","journal-title":"J Hosp Infect"},{"issue":"2","key":"10.1016\/j.ijid.2018.05.017_bib0425","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1086\/375821","article-title":"Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City","volume":"37","author":"Quale","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2018.05.017_bib0430","first-page":"307","article-title":"Ventilator-associated pneumonia due to colistin susceptible-only microorganisms","volume":"30","author":"Rios","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2018.05.017_bib0435","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s15010-010-0008-1","article-title":"Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii Bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes","volume":"38","author":"Rousti","year":"2010","journal-title":"Infection"},{"issue":"4","key":"10.1016\/j.ijid.2018.05.017_bib0440","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s15010-014-0635-z","article-title":"Characteristics, risk factors and outcomes of adult cancer patients with extensively drug-resistant Pseudomonas aeruginosa infections","volume":"42","author":"Samonis","year":"2014","journal-title":"Infection"},{"issue":"2","key":"10.1016\/j.ijid.2018.05.017_bib0445","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/jac\/28.2.199","article-title":"Role of OmpD2 and chromosomal beta-lactamase in carbapenem resistance in clinical isolates of Pseudomonas aeruginosa","volume":"28","author":"Satake","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2018.05.017_bib0450","doi-asserted-by":"crossref","first-page":"e764","DOI":"10.1016\/j.ijid.2010.02.2254","article-title":"A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii","volume":"14","author":"Sheng","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2018.05.017_bib0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/668770","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010","volume":"34","author":"Sievert","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijid.2018.05.017_bib0460","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0195-6701(03)00046-X","article-title":"Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment","volume":"54","author":"Smolyakov","year":"2002","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijid.2018.05.017_bib0465","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1128\/AAC.33.8.1202","article-title":"Decreased outer membrane permeability in imipenem-resistant mutants of Pseudomonas aeruginosa","volume":"33","author":"Trias","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2018.05.017_bib0470","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1086\/516092","article-title":"Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns","volume":"25","author":"Troillet","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2018.05.017_bib0475","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1164\/ajrccm.157.2.9705064","article-title":"Ventilator-associated pneumonia caused by potentially drug-resistant bacteria","volume":"157","author":"Trouillet","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.ijid.2018.05.017_bib0480","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bjid.2012.06.009","article-title":"Risk factors for pan-resistant Pseudomonas aeruginosa bacteremia and the adequacy of antibiotic therapy","volume":"16","author":"Tuon","year":"2012","journal-title":"Braz J Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2018.05.017_bib0485","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1086\/595977","article-title":"Nosocomial outbrak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital","volume":"30","author":"Valencia","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijid.2018.05.017_bib0490","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/00365548.2012.724178","article-title":"Risk factors and outcomes in patients with carbapenem-resistant Acinetobacter infection","volume":"45","author":"Vitkauskiene","year":"2013","journal-title":"Scand J Infect Dis"},{"issue":"5","key":"10.1016\/j.ijid.2018.05.017_bib0495","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1128\/AAC.01758-13","article-title":"A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa","volume":"58","author":"Voor in \u2018t Holt","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2018.05.017_bib0500","series-title":"The Newcastle-Ottawa Scale (NOS) assessing the quality of nonrandomised studies in meta-A for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2013"},{"issue":"10","key":"10.1016\/j.ijid.2018.05.017_bib0505","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.ajic.2008.07.006","article-title":"Investigation of nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa","volume":"36","author":"Yakupogullari","year":"2008","journal-title":"Am J Infect Control"},{"issue":"4","key":"10.1016\/j.ijid.2018.05.017_bib0510","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009947","article-title":"Multidrug resistant Acinetobacter baumannii: risk factors for appearance of imipenem resistant stains on patients formerly with susceptible strains","volume":"5","author":"Ye","year":"2010","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.ijid.2018.05.017_bib0515","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1086\/521660","article-title":"Epidemiologic, clinical and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit","volume":"28","author":"Young","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijid.2018.05.017_bib0520","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jhin.2004.09.007","article-title":"Risk factors for imipenem-resistant Pseudomonas Aeruginosa: a comparative analysis of 2 case-control studies in hospitalized patients","volume":"59","author":"Zavascki","year":"2005","journal-title":"J Hosp Infect"},{"issue":"7","key":"10.1016\/j.ijid.2018.05.017_bib0525","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.ajic.2013.01.006","article-title":"Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia","volume":"41","author":"Zheng","year":"2013","journal-title":"Am J Infect Control"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971218344278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971218344278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T23:20:12Z","timestamp":1661383212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971218344278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":105,"alternative-id":["S1201971218344278"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2018.05.017","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Importance of control groups when delineating antibiotic use as a risk factor for carbapenem resistance, extreme-drug resistance, and pan-drug resistance in Acinetobacter baumannii and Pseudomonas aeruginosa: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2018.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}